A
Agilent Technologies Inc.
Healthcare •
Diagnostics & Research •
stocks •
XNYS
• usd
$132.98
+$0.84
(+0.64%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $37.70B | EPS (ttm) | $4.57 | Current Price | $132.98 |
| Enterprise Value | $39.45B | Forward EPS | $6.55 | Previous Close | $132.14 |
| P/E Ratio | 29.10 | ROA | 8.49% | 52W High | $160.27 |
| Forward P/E | 20.31 | ROE | 20.62% | 52W Low | $96.43 |
| PEG Ratio | - | Gross Margin | 52.43% | 50 Day Avg | $142.13 |
| P/S Ratio | 5.43 | Operating Margin | 26.38% | 200 Day Avg | $128.09 |
| P/B Ratio | 5.58 | Profit Margin | 18.75% | Volume | 1.96M |
| EV/EBITDA | 20.17 | Current Ratio | 1.96 | Avg Volume | 2.00M |
| EV/Sales | 5.68 | Quick Ratio | 1.44 | Beta | 1.30 |
| Employees | 18.10K | Debt/Equity | 52.56 | Shares Outstanding | 283.50M |
| Sector | Healthcare | Total Debt | $3.54B | Float Shares | 282.64M |
| Industry | Diagnostics & Research | Total Cash | $1.79B | Short Float | 1.60% |
| Optionable | Yes | Cash/Share | $6.31 | Short Ratio | 1.99 |
| Dividend Yield | 77.00% | Book Value/Share | $23.82 | % Held by Insiders | 0.32% |
| Target Price | $169.67 | Revenue (TTM) | $6.95B | % Held by Institutions | 92.66% |